Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement Pharmaceutical Investing
BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights Pharmaceutical Investing
Mindset Pharma Presents Poster at Neuroscience 2022 Highlighting Preclinical Data on MSP-1014, its Psilocybin-like Lead Drug Candidate Life Science Investing
Lygos and Ginkgo Bioworks Announce Partnership to Optimize Production of Biobased Specialty Chemicals Life Science Investing
BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences Pharmaceutical Investing
BriaCell Reports Positive Breast Cancer Efficacy Data with Bria-IMT Immunotherapy Treatment at SITC Annual Meeting Pharmaceutical Investing
Health Canada Approves Camzyos for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy Pharmaceutical Investing
Sirona Biochem Signs Research Collaboration Agreement with International Centre for Genetic Engineering and Biotechnology Life Science Investing
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress Life Science Investing
